Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
218 studies found for:    Open Studies | "Colitis, Ulcerative"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Device: C2 videos;   Procedure: colonoscopy
2 Recruiting Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Condition: Colitis, Ulcerative
Intervention: Other: No Intervention
3 Recruiting Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
Condition: Colitis, Ulcerative
Intervention: Drug: Golimumab
4 Not yet recruiting GSK2982772 Study in Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: GSK2982772;   Drug: Placebo
5 Recruiting Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: SB012;   Drug: Placebo
6 Not yet recruiting Mercaptopurine Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Mercaptopurine (Purinethol);   Drug: Placebo;   Drug: Mesalamine;   Drug: Prednisone
7 Recruiting Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention:
8 Recruiting An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: LYC-30937-EC;   Drug: Placebo
9 Not yet recruiting Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: LYC-30937-EC
10 Recruiting Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
Condition: Colitis, Ulcerative
Intervention: Drug: PF-06480605
11 Recruiting An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: Vedolizumab 300 mg
12 Recruiting Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
Condition: Colitis, Ulcerative
Intervention: Biological: Golimumab
13 Recruiting An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab;   Drug: Adalimumab placebo;   Drug: Adalimumab;   Drug: Vedolizumab placebo
14 Recruiting Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab IV 300 mg;   Drug: Placebo IV;   Drug: Vedolizumab SC 108 mg;   Drug: Placebo SC
15 Recruiting Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Adalimumab;   Other: Placebo
16 Recruiting Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Infliximab
17 Not yet recruiting Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: berberine;   Drug: regular treatment
18 Not yet recruiting Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Flaxseed lignan-enriched complex (FLC);   Other: Placebo
19 Recruiting Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Apremilast;   Drug: Placebo
20 Recruiting Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: Adalimumab;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.